Detection of anti-BP180 NC16A autoantibodies after the onset of dipeptidyl peptidase-IV inhibitor-associated bullous pemphigoid: a report of three patients

Br J Dermatol. 2018 Sep;179(3):790-791. doi: 10.1111/bjd.16656. Epub 2018 Jun 25.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Autoantibodies / blood*
  • Autoantibodies / immunology
  • Autoantigens / immunology*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dipeptidyl-Peptidase IV Inhibitors / adverse effects*
  • Female
  • Humans
  • Male
  • Non-Fibrillar Collagens / immunology*
  • Pemphigoid, Bullous / blood
  • Pemphigoid, Bullous / chemically induced*
  • Pemphigoid, Bullous / diagnosis
  • Pemphigoid, Bullous / immunology
  • Pyrazoles / adverse effects
  • Thiazolidines / adverse effects
  • Time Factors
  • Vildagliptin / adverse effects

Substances

  • 3-(4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-ylcarbonyl)thiazolidine
  • Autoantibodies
  • Autoantigens
  • Dipeptidyl-Peptidase IV Inhibitors
  • Non-Fibrillar Collagens
  • Pyrazoles
  • Thiazolidines
  • collagen type XVII
  • Vildagliptin